Home Analyst Ratings Cabaletta Bio Initiated At Buy by Chardan Capital

Cabaletta Bio [CABA] Initiated At Buy by Chardan Capital

Chardan Capital launched its Cabaletta Bio [CABA] rating to the equivalent of Buy and assigned the price target of $21.0, in a research note dated 2021-01-08. That figure represents around a 60.67% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Morgan Stanley’s analysts assigning the shares to “an Overweight” rating in a research note to investors issued in mid November. Meanwhile, Evercore ISI had launched its coverage on CABA with “an Outperform”, in a research note produced for clients November 19, 2019. In addition, Cowen launched coverage on November 19, 2019. The research firm rated CABA “an Outperform”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Cabaletta Bio Inc. [NASDAQ:CABA] a Good Buy Right Now?

It should be noted that CABA technical indicators for short, intermediate as well as long term progress have placed an overall average of 40% as Buy. The average signal changed from 40% Buy in the last week and compares with 100% Buy in the past month. Data from Cabaletta Bio Inc.’s Trend Spotter indicated that the signals were Weakest. The stock current average is 0.14 million shares in the past 20 days and the short term average signal indicates a Hold. In the last 50 days, the average trading volume was 89830.0 shares while the medium term average advocated for 50% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 85398.0 shares.

CABA Price Performance

On Wall Street, Cabaletta Bio Inc. [NASDAQ:CABA] finished Thursday’s session up 1.08% at $13.07. The stock went up to $13.42 at the same session while its lowest single day price was $12.75. In the last five days, it saw a rise of about 6.69%, Cabaletta Bio Inc. shares gained by almost 4.73% since the beginning of the year. However, the share price has dropped to as low as -33.42% below its one year high. On 01/07/21, the company shares recorded $13.42, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $12.24. The company’s shares have declined by -15.13% in the past year. The 50-day SMA achieved is $13.57 while the 200-day SMA is $10.69. Volume dropped to 77928.0 from 0.12 million in the previous session.

CABA Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 12.74 level, and in case of violation of this particular level, it will cause more drop to 12.41 level. On the upper level, 13.75 is still the key resistance. The stock may increase to the subsequent resistance at 13.41. The Relative Strength Index (RSI) pinned on the 14-day chart is 47.11, implying a neutral technical stance while the MACD stands at 0.13, meaning price will decrease in the next trading period. Percent R indicator moved to 43.94%, implying low price movement. Stochastic %K at 45.30% suggest selling the stock.

What is the short interest in Cabaletta Bio Inc.?

Short interest in the Cabaletta Bio Inc. stock has plunged, decreasing by -0.15 million shares to total 1.36 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 1.21 million, data from Yahoo Finance shows. The increase of 11.03% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 7.07% of the overall float for the stock.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Cabaletta Bio Inc.’s Biggest Shareholders: Who Owns Cabaletta Bio Inc. [CABA]?

Filings by Adage Capital Management LP showed that the firm now holds a total of 3,404,760 shares or roughly 14.15% of the outstanding CABA shares. This means their shares have reduced by -160,249 from the 3,404,760 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Cormorant Asset Management LP updated stake is worth $30,761,454. Details in the latest 13F filings reveal that Tavistock Life Sciences Co. disposed off their 0.00% stake valued at $23,307,452 while Redmile Group LLC cut theirs at $20,632,370. During the last quarter, Tavistock Life Sciences Co. liquidated 0 of its shares in Cabaletta Bio Inc. while Redmile Group LLC sold -39,312 shares. The Baker Bros. Advisors LP’s holdings currently number 636,363 shares at $8317264.41. According to the firm’s last 13F report, Millennium Management LLC shares in the company at filing stood at 601,830 shares, roughly $8,955,230.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

ReTo Eco-Solutions, Inc. (RETO) Stock Fell 6% In Pre-Market Trading

The provider of technology solutions around ecological environments ReTo Eco-Solutions, Inc. (NASDAQ: RETO) has been facing a drop in its stock price in pre-market...

Fulgent Genetics (FLGT) Stock Rocketed 34.46% In Extended Trading Following Strong Financial Results

Shares of the testing services and comprehensive testing solutions technology company Fulgent Genetics, Inc. (NASDAQ: FLGT) rocketed 34.46% in the after-hour trades on Thursday....

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

After An Impressive 300% Rally, Why Did Second Sight Medical Products (EYES) Get Dropped After-Hours?

Shares of the implantable visual prosthetics company, Second Sight Medical Products, Inc. (NASDAQ: EYES) have seen a fall of -12.61% in after-hours trading on...

After-Hours Market: More Gains For Bionano Genomics (BNGO)

Bionano Genomics, Inc. (Nasdaq: BNGO) saw its stock price continue rising even after the ring of the bell on Friday. The company gained 7.13%...

Related News

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.